ClassID:

92609

C07C219/04 - CPC Classification

Classification description:

Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated

Sub-classes:
Recent Application in this class:
#1
20250170062
2025-05-29

NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF

#2
20250162978
2025-05-22

CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF

#3
20250152512
2025-05-15

NITROGEN-BRANCHED NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF

#4
20250074866
2025-03-06

MODIFIED AMINE LIPIDS

#5
20240246898
2024-07-25

CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF

#6
20230331656
2023-10-19

NANOMATERIALS COMPRISING ACETALS

#7
20230100940
2023-03-30

DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases

#8
20220119341
2022-04-21

Modified amine lipids

#9
20210078936
2021-03-18

Lipids and lipid compositions for the delivery of active agents

#10
20200331853
2020-10-22

Carbondisulfide derived zwitterions

#11
20200093831
2020-03-26

DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases

#12
20190292130
2019-09-26

Cationic lipids for nucleic acid delivery and preparation thereof

#13
20190233372
2019-08-01

Carbondisulfide derived zwitterions

#14
20180290965
2018-10-11

Lipids and lipid compositions for the delivery of active agents

#15
20160311759
2016-10-27

Lipids and lipid compositions for the delivery of active agents

#16
20150329486
2015-11-19

Carbondisulfide derived zwitterions

#17
20150197484
2015-07-16

Use of cannabidiol prodrugs in topical and transdermal administration with microneedles

#18
20150152045
2015-06-04

Reactive ionic liquids

#19
20150152034
2015-06-04

Pharmaceutically acceptable salts of fatty acids

#20
20150048351
2015-02-19

Compound having acridan ring structure, and organic electroluminescent device

#21
20140275064
2014-09-18

DYRK1 inhibitors and uses thereof

#22
20130075715
2013-03-28

Compound having acridan ring structure, and organic electroluminescent device

#23
20110052694
2011-03-03

USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES

#24
20110045359
2011-02-24

Reactive ionic liquids

#25
20090036523
2009-02-05

Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same

#26
20050277611
2005-12-15

Cationic cardiolipin analoges and its use thereof